Luyan Pharma Co.,Ltd. (SHE:002788)
13.76
-0.40 (-2.82%)
Apr 29, 2026, 3:04 PM CST
Luyan Pharma Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,501 | 8,229 | 3,190 | 3,493 | 3,236 | 3,034 | Upgrade
|
| Market Cap Growth | 74.38% | 157.98% | -8.68% | 7.92% | 6.66% | -1.51% | Upgrade
|
| Enterprise Value | 10,198 | 12,798 | 7,860 | 8,216 | 7,721 | 7,052 | Upgrade
|
| Last Close Price | 14.16 | 21.18 | 7.88 | 8.31 | 7.45 | 6.74 | Upgrade
|
| PE Ratio | 19.67 | 29.30 | 9.23 | 9.61 | 9.38 | 9.92 | Upgrade
|
| PS Ratio | 0.26 | 0.39 | 0.16 | 0.18 | 0.17 | 0.17 | Upgrade
|
| PB Ratio | 1.69 | - | 1.00 | 1.17 | 1.16 | 1.19 | Upgrade
|
| P/TBV Ratio | 2.12 | - | 1.27 | 1.52 | 1.44 | 1.49 | Upgrade
|
| P/FCF Ratio | 12.10 | 18.10 | 14.74 | 4.48 | - | - | Upgrade
|
| P/OCF Ratio | 7.99 | 11.95 | 5.52 | 2.67 | 13.94 | - | Upgrade
|
| EV/Sales Ratio | 0.48 | 0.60 | 0.38 | 0.41 | 0.40 | 0.40 | Upgrade
|
| EV/EBITDA Ratio | 13.89 | 19.05 | 10.47 | 10.90 | 10.19 | 10.77 | Upgrade
|
| EV/EBIT Ratio | 17.07 | 21.43 | 11.49 | 11.82 | 10.99 | 11.75 | Upgrade
|
| EV/FCF Ratio | 22.43 | 28.15 | 36.33 | 10.54 | - | - | Upgrade
|
| Debt / Equity Ratio | - | - | 1.55 | 1.63 | 1.82 | 1.75 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 6.09 | 5.96 | 6.23 | 6.29 | Upgrade
|
| Debt / FCF Ratio | - | - | 22.88 | 6.23 | - | - | Upgrade
|
| Net Debt / Equity Ratio | - | - | 1.37 | 1.43 | 1.61 | 1.59 | Upgrade
|
| Net Debt / EBITDA Ratio | - | - | 5.83 | 5.64 | 5.92 | 6.22 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 20.22 | 5.45 | -47.03 | -6.61 | Upgrade
|
| Asset Turnover | - | - | 1.68 | 1.68 | 1.79 | 1.89 | Upgrade
|
| Inventory Turnover | - | - | 6.97 | 7.16 | 7.44 | 7.52 | Upgrade
|
| Quick Ratio | - | - | 0.77 | 0.79 | 0.79 | 0.80 | Upgrade
|
| Current Ratio | - | - | 1.15 | 1.16 | 1.17 | 1.19 | Upgrade
|
| Return on Equity (ROE) | - | - | 11.27% | 12.64% | 13.12% | 12.17% | Upgrade
|
| Return on Assets (ROA) | - | - | 3.50% | 3.68% | 4.03% | 4.04% | Upgrade
|
| Return on Invested Capital (ROIC) | - | 11.71% | 7.10% | 7.44% | 7.61% | 7.35% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 17.00% | 18.40% | 20.20% | 20.20% | Upgrade
|
| Earnings Yield | 5.11% | 3.41% | 10.84% | 10.41% | 10.66% | 10.08% | Upgrade
|
| FCF Yield | 8.26% | 5.53% | 6.78% | 22.33% | -2.95% | -20.29% | Upgrade
|
| Dividend Yield | 2.47% | - | 4.44% | 3.61% | 4.03% | 4.45% | Upgrade
|
| Payout Ratio | 111.78% | 111.78% | 93.69% | 93.56% | 95.92% | 81.76% | Upgrade
|
| Buyback Yield / Dilution | 0.32% | -0.45% | -0.42% | 0.28% | -0.17% | -7.46% | Upgrade
|
| Total Shareholder Return | 2.85% | -0.45% | 4.02% | 3.89% | 3.86% | -3.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.